245
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Effects of mTOR Inhibitors in Prevention of Abdominal Adhesions

, MD, , MD, , MSc, , PhD & , MD, PhD
Pages 275-281 | Received 02 Nov 2015, Accepted 30 Dec 2015, Published online: 16 Mar 2016

REFERENCES

  • Ellis H. Postoperative intra-abdominal adhesions: A personal view. Colorectal Dis 2007;9(Suppl 2):3–8.
  • Menzies D, Ellis H. Intestinal obstruction from adhesions: How big is the problem? Ann R Coll Surg Engl 1990;72:60–63.
  • Bruggmann D, Tchartchian G, Wallwiener M, et al. Intra-abdominal adhesions: Definition, origin, significance in surgical practice, and treatment options. Dtsch Arztebl Int 2010;107:769–775.
  • Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, et al. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000;87:467–471.
  • Schreinemacher MH, ten Broek RP, Bakkum EA, et al. Adhesion awareness: A national survey of surgeons. World J Surg 2010;34:2805–2812.
  • Reed KL, Fruin AB, Bishop-Bartolomei KK, et al. Neurokinin-1 receptor and substance P messenger RNA levels increase during intra-abdominal adhesion formation. J Surg Res 2002;108:165–172.
  • Cheong YC, Laird SM, Li TC, et al. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001;7:556–566.
  • Sulaiman H, Dawson L, Laurent GJ, et al. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 2002;30:126–131.
  • Holmdahl L, Eriksson E, al-Jabreen M, et al. Fibrinolysis in human peritoneum during operation. Surgery 1996;119:701–705.
  • Kanko M, Ozbudak E, Ozerdem A, et al. Effect of sirolimus in the prevention of adhesions around intra-abdominal prosthetic graft. World J Surg 2006;30:1648– 1652.
  • Hoshino A, Kawamura YI, Yasuhara M, et al. Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 2007;178:5296–5304.
  • Ergul E, Korukluoglu B. Peritoneal adhesions: Facing the enemy. Int J Surg 2008;6:253–260.
  • Binnebosel M, Rosch R, Junge K, et al. Macrophage and T-lymphocyte infiltrates in human peritoneal adhesions indicate a chronic inflammatory disease. World J Surg 2008;32:296–304.
  • Suzuki T, Kono T, Bochimoto H, et al. An injured tissue affects the opposite intact peritoneum during postoperative adhesion formation. Sci Rep 2015;5:1–11. Doi:10.1038/srep07668
  • Bootun R. Effects of immunosuppressive therapy on wound healing. Int Wound J 2013;10:98–104.
  • Adelman SJ. Sirolimus and its analogs and its effects on vascular diseases. Curr Pharm Des 2010;16:4002–4011.
  • Hao H, Ishibashi-Ueda H, Tsujimoto M, et al. Drug-eluting stent: Importance of clinicopathological correlations. Circ J 2011;75:1548–1558.
  • Maciver AH, McCall MD, Edgar RL, et al. Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model. Surgery 2011;150:907–915.
  • Larsen JL, Bennett RG, Burkman T, et al. Tacrolimus and sirolimus cause insulin resistance in normal Sprague Dawley rats. Transplantation 2006;82:466–470.
  • Willems MC, Hendriks T, de Man BM, et al. Everolimus-induced loss of wound strength can be prevented by a short postoperative delay in its administration. Wound Repair Regen 2011;19:680–686. Doi:10.1111/j.1524-475X.2011.00730.x. Epub 2011 Oct 10.
  • Greene AK, Alwayn IP, Nose V, et al. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg 2005;242:140–146.
  • Linsky CB, Diamond MP, Cunningham T, et al. Adhesion reduction in the rabbit uterine horn model using an absorbable barrier, TC-7. J Reprod Med 1987;32:17–20.
  • Sopel M, Falkenham A, Oxner A, et al. Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis. Int J Exp Pathol 2012;93:115–124.
  • Falkenham A, Sopel M, Rosin N, et al. Early fibroblast progenitor cell migration to the AngII-exposed myocardium is not CXCL12 or CCL2 dependent as previously thought. Am J Pathol 2013;183:459–469.
  • Yaffe PB, Doucette CD, Walsh M, et al. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells. Exp Mol Pathol 2013;94:109–114.
  • MacMillan HF, Lee T, Issekutz AC. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation. Clin Immunol 2009;132:222–233.
  • Ward BC, Panitch A. Abdominal adhesions: Current and novel therapies. J Surg Res 2011;165:91–111.
  • Zhou J, Lee JM, Jiang P, et al. Reduction in postsurgical adhesion formation after cardiac surgery by application of N,O-carboxymethyl chitosan. J Thorac Cardiovasc Surg 2010;140:801–806.
  • Hermanowicz A, Debek W, Oksiuta M, et al. Peritoneal cell response during adhesion formation. J Invest Surg 2010;23(5):267–272.
  • Rodgers KE, Girgis W, St Amand K, et al. Reduction of adhesion formation by intraperitoneal administration of various anti-inflammatory agents. J Invest Surg 1998;11(5):327–339.
  • Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet 1999;353:1476– 1480.
  • Margenthaler JA, Longo WE, Virgo KS, et al. Risk factors for adverse outcomes following surgery for small bowel obstruction. Ann Surg 2006;243:456–464.
  • Cimen SG, Atila K, Cimen S, et al. Impact of polyethylene glycol and dextran 70 treatment on adhesion formation after subtotal thyroidectomy. Int J Surg Res 2013;2:8–12.
  • Laschke MW, Haufel JM, Roller J, et al. Rapamycin but not cyclosporin A inhibits vascularization and incorporation of implanted surgical meshes. Transpl Int 2009;22:654–662. Doi:10.1111/j.1432-2277.2009.00841.x. Epub 2009 Feb 5.
  • Dietrich A, Bouzidi M, Hartwig T, et al. Rapamycin and a hyaluronic acid-carboxymethyl cellulose membrane did not lead to reduced adhesion formations in a rat abdominal adhesion model. Arch Gynecol Obstet 2012;285:1603–1609.
  • Zuhlke HV, Lorenz EM, Straub EM, et al. Pathophysiology and classification of adhesions. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir 1990:1009–1016.
  • Kramer K, Senninger N, Herbst H, et al. Effective prevention of adhesions with hyaluronate. Arch Surg 2002;137:278–282.
  • van der Vliet JA, Willems MC, de Man BM, et al. Everolimus interferes with healing of experimental intestinal anastomoses. Transplantation 2006;82:1477–1483.
  • Willems MC, van der Vliet JA, de Man BM, et al. Persistent effects of everolimus on strength of experimental wounds in intestine and fascia. Wound Repair Regen 2010;18:98–104.
  • Nashan B, Citterio F. Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: A critical review of the literature. Transplantation 2012;94:547–561.
  • Azzola A, Havryk A, Chhajed P, et al. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. Transplantation 2004;77:275–280.
  • Dutly AE, Gaspert A, Inci I, et al. The influence of the rapamycin-derivate SDZ RAD on the healing of airway anastomoses. Eur J Cardiothorac Surg 2003;24:154–158.
  • Kahn D, Spearman CW, Mall A, et al. The effect of rapamycin on the healing of the ureteric anastomosis and wound healing. Transplant Proc 2005;37:830–831.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.